VE-821

Descriptions

Application

VE-821 has been used as an inhibitor of ATM- and Rad3-related (ATR) protein in human cancer cells.

Biochem/physiol Actions

VE-821 is a potent ATP-competitive inhibitor of the DNA damage response (DDR) kinase Ataxia telangiectasia-mutated (ATM) and ATM- and Rad3-related (ATR) with a Ki of 13 nM. VE-821 has minimal cross-reactivity against the related PIKKs ATM, DNA-dependent protein kinase (DNA-PK), mTOR and PI3-kinase-γ (Ki of 16 µM, 2.2 µM, >1 µM and 3.9 µM, respectively) and against a large panel of unrelated protein kinases. VE-821 used alone caused death in a large fraction of cancer cell populations and also showed strong synergy with genotoxic agents. VE-821 increased sensitivity of cells to radiation and also sensitized cancer cells to a variety of chemotherapeutic agents.

Other Notes

VE-821 has been expertly reviewed and recommended by the Chemical Probes Portal. For more information, please visit the VE-821 probe summary on the Chemical Probes Portal website.

Packaging

5, 25 mg in glass bottle

Specifications

No detailed specifications are available for this product.

Downloads

There are no downloads for this product.

Code	Description	Colour	Quality Level	InChI key	InChI	Manufacturer	Solubility	Form	Assay	Price
3574883	VE-821	white to beige	100	DUIHHZKTCSNTGM-UHFFFAOYSA-N	1S/C18H16N4O3S/c1-26(24,25)14-9-7-12(8-10-14)15-11-20-17(19)16(22-15)18(23)21-13-5-3-2-4-6-13/h2-11H,1H3,(H2,19,20)(H,21,23)	SIGMA-ALDRICH	H2O: 10 mg/mL, clear, DMSO: 10 mg/mL, clear	powder	≥98% (HPLC)	You need to be logged in to see prices.
3574884	VE-821	white to beige	100	DUIHHZKTCSNTGM-UHFFFAOYSA-N	1S/C18H16N4O3S/c1-26(24,25)14-9-7-12(8-10-14)15-11-20-17(19)16(22-15)18(23)21-13-5-3-2-4-6-13/h2-11H,1H3,(H2,19,20)(H,21,23)	SIGMA-ALDRICH	H2O: 10 mg/mL, clear, DMSO: 10 mg/mL, clear	powder	≥98% (HPLC)	You need to be logged in to see prices.